Senaste nyheterna

Emilia, industrial doctoral student at Gedea and Karolinska Institutet

Emilia Lahtinen is an industrial Ph.D. student at Gedea and at Karolinska Institutet. Her project has the title Bacterial vaginosis: Understanding…

Anna-Karin Areskog strengthens the team

Gedea has recently strengthened its team by hiring Anna-Karin Areskog as QA Director. Anna-Karin has been a consultant with the company since April…

Gedea´s share issue oversubscribed by 54%

Gedea Biotech AB carried out a rights issue of SEK 24.3 million during October. The interest from both existing owners and new investors exceeded the…

Per-Ola Forsberg new CFO at Gedea

We are pleased to announce that Per-Ola Forsberg has been appointed as the new CFO of Gedea since April 20th. Per-Ola holds a degree in business…

Nya insikter om de bakteriella biomet, mikrober.

Gedea Biotech selected for prestigious grant funding from the European Innovation Council, EIC

Yesterday, the EIC announced that Gedea Biotech has been selected for the €2.5M EIC Accelerator grant for the continued development and…

The Swedish femtech company Gedea Biotech completes important clinical trial on vaginal fungal infection

The Swedish femtech company Gedea Biotech, which is developing an antibiotic-free treatment for vaginal infections, today announced that all patients…


Press kit

Klicka för att ladda ner logotyper och bilder

Gedea Biotech, vit logotyp.
Gedea Biotech, vit logotyp.

Gedea Biotech AB
Medicon Village
Scheeletorget 1
223 81 Lund
Sweden

Julie Waras Brogren, CEO
julie.brogren@gedeabiotech.com
073-352 67 63